NEWS
01.02.2012
In mid-December 2011 were summed up the international online contest for young scientists «Alexander A. Maximow Award for Cellular Therapy and Transplantation - 2011/2012 »on the best scientific work, reflecting advances in cell transplantation, as well as innovative ideas in regenerative medicine to promote human progress.
14.11.2011
Due to the fact that this issue of the journal is devoted to the prospective field of basic and clinical angiology- therapeutic angiogenesis- the editors applied to the practicing surgeons with the following question: as clinical physicians are you satisfied with the available set of surgical and pharmaceutical means of treating the lower limbs vessels?
16.10.2011
26.09.2011
20.08.2011
29.04.2011
05.08.2010
Transplantation of hematopoietic stem cells (HSCs) has been used to treat malignant hematological and immunologic disorders, hereditary metabolic disorders for some decades. Its success is determined to a large extent by the number of CD34+ hematopoietic cells in a transplant (bone marrow, peripheral or umbilical cord blood).
16.04.2010
Generation of pluripotency in somatic cells became possible three years ago, when Japanese scientists S.Yamanaka and K.Takahashi described pluripotent cells derived from mouse fibroblast cells as a result of retroviral transfection of four genes - Oct4, Klf4, Sox2 and c-Myc (OKSM) and called them induced pluripotent stem cells (iPS cells)
Volume
VII
№1, 2012 - The actual number
Reviews
Developing direction cellular medicine is the use of the unique properties of progenitor cells with high biological activity and potential for differentiation. Multipotent mesenchymal stromal cells (MMSC) are pluripotent stem cells, has several important properties for clinical use.
Implantation of artifitial heart valve prostheses is assotiated with several serious complications. Therefore, there is a need in new approaches of preparing heart valve prostheses.
Original research
Personalized cell therapy in ophthalmology (II): cytokine profile of the autologous cellular product
Clinical experience
The clinical and experimental study on the restoration of
bone tissue with tissue engineering scaffold based on stem
cells of adipose tissue and resorbable osteoplastic matrix. In a
pilot study proved the effectiveness of the transplant, founded
the dates of dental implantation.
Discussion and general theoretical work
Mediaarhiv
International Educational Seminar "Cell Technologies in Plastic and Reconstructive Surgery"
M.A Kurtser. Modern possibilities of IVF and diagnostic predimplatatsionnoy
A. Madrigal. Immunological properties of umbilical cord blood
IV International Symposium "Actual questions of cell technology: The practice of transplantation, cord blood stem cells"
E. Gluckman - Results of transplantation of umbilical cord blood cells in hematological diseases
III International Symposium "Actual issues of stem cell technologies"
S.L Kiselev - pluripotent human cells as the source of the biotechnological production of blood components
T. Ton - European regulation of registration of high-tech medicines (ATMP) and its impact on public and private cord blood banks
B.V Afanasyev - Results of the various types of allogeneic hematopoietic stem cells in adults and children
A. Kuliev Preimplantation diagnostikasozdanie effective tool for HLA-matched transplants
A roundtable of guests of the Symposium, the leaders of cord blood banks and the media
Roman Deev, Human Stem Cell Institute
A.A Artemyev